baber/WOPTO huggingface dataset:
Patent AU-2020350803-A1 (AU)
Title: Wine barrel or stillage rack locking mechanism
Inventor: CAMPBELL GEORGE
IPC: A47B87/02
Filed: 2020-09-16
Abstract: There is proposed a wine barrel or stillage rack assembly, comprising a plurality of rack members, each rack member including a body for supporting wine barrel/s or stillage vessel/s thereon, and at least two legs attached to the body, wherein the plurality of rack members being stackable such that each of said at least two legs being configured to engage an underlying and/or an overlying rack member of said wine barrel or stillage rack assembly. The wine barrel or stillage rack assembly further including at least one locking member attached to or engaging at least one of the legs of each rack member, wherein said at least one locking member being configured to engage a leg of said underlying or said overlying rack member, to thereby inhibit separation of adjacent rack members.
Patent AU-2020372184-A1 (AU)
Title: Method and apparatus for detecting changes in blood flow in the head of a subject
Inventor: VAN BOHEMEN SAMUEL JACOBUS
IPC: A61B5/369
Filed: 2020-08-27
Abstract: A method of detecting changes in blood flow in a head of a subject comprises measuring a value of a parameter of a cardiac bioelectrical signal at a scalp area of the subject relative to a reference cardiac bioelectrical signal. The method also includes comparing the value of the measured parameter with a predetermined value of the parameter to determine any change in blood flow in the head of the subject. The determined change can be used to detect changes in perfusion in the brain of a subject for example, as a result of anti-coagulation medication used to dissolve a clot in a blood vessel of the brain of a subject who has experienced ischaemic stroke.
Patent AU-2020380588-A1 (AU)
Title: Anti IL-33 therapeutic agent FPR treating renal disorders
Inventor: BAKER DAVID
IPC: A61P13/12
Filed: 2020-11-03
Abstract: The present disclosure relates to a method of treating kidney injury, by administering an anti-IL- 33 therapeutic agent which inhibits both ST2 signaling and RAGE signaling.
Patent AU-2020402029-A1 (AU)
Title: Quantification of polynucleotide analytes from dried samples
Inventor: NAIR SANGEETHA VIJAYSRI
IPC: C12Q1/6834
Filed: 2020-12-09
Abstract: Presented are methods, systems, and software products useful for determining the concentration of an analyte in a fluid specimen used to produce a dried sample, where the dried sample serves as a source of the analyte in a detection and quantification procedure. Particularly illustrated is the use of dried blood spots for quantifying a polynucleotide analyte.
Patent AU-2020413284-A1 (AU)
Title: Aliphatic acid amide derivative
Inventor: FUJII YUKI
IPC: A61P25/18
Filed: 2020-12-23
Abstract: The present invention relates: to a compound represented by formula (1), the compound having antagonist activity against serotonin 5-HT
Patent AU-2021201203-A1 (AU)
Title: Deck wrench disengage with pipe unscrewed interlock
Inventor: MOBERG CARL J
IPC: E21B19/16
Filed: 2021-02-24
Abstract: DECK WRENCH DISENGAGE WITH PIPE UNSCREWED INTERLOCK 
In accordance with one aspect of the present disclose, an interlock system (100) 
for a mobile drilling machine (1). The interlock system has a sensor assembly (40) used to 
determine a drill string status, an operator interface (110) for receiving a deck wrench 
disengagement input (115), and a control module (112). The control module may be used to 
receive the deck wrench disengagement input from the operator interface, receive the drill string 
status from the sensor assembly, determine from the drill string status that a drill string 
component (20) engaged by the deck wrench (28) is connected to a drill string (15) or a drill 
head (12), and disengage the deck wrench from the drill string component engaged by the deck 
wrench.
19-1273AU01 1/11 
rI 
-- 6 
10 
9 8 
FIG. 1
Patent AU-2021201533-A1 (AU)
Title: Sterilization units, systems, and methods
Inventor: ROMO LUIS FERNANDO
IPC: A61L2/10
Filed: 2021-03-10
Abstract: STERILIZATION UNITS, SYSTEMS, AND METHODS 
ABSTRACT 
A sterilization device (1000) comprising: a UV-C radiation source (1060) configured to 
emit UV-C radiation; and a room partition (1200, 1300, 1400, 1500) selectably configurable 
between two or more different partition geometries and configured, in each of the two or more 
different partition geometries, to (a) physically separate floor space of a room into a sterilization 
target area and a non-target area, and (b) direct the UV-C radiation to the target area from at 
least two different directions while shielding the non-target area from the UV-C radiation; and 
wherein the room partition (1200, 1300, 1400, 1500) includes casters (1050) to allow the room 
partition (1200, 1300, 1400, 1500) to be rolled between multiple configurations.
Patent AU-2021201703-A1 (AU)
Title: Calcium cyanamide fertilizer with triazone
Inventor: SONDGROTH BROC
IPC: A01N43/38
Filed: 2021-03-18
Abstract: CALCIUM CYANAMIDE FERTILIZER WITH TRIAZONE 
ABSTRACT OF THE DISCLOSURE 
The present invention is a liquid fertilizer comprising a calcium cyanamide component 
that is dissolved, co-applied, dispersed, or suspended in a solution of aqueous triazone urea. The 
combination of calcium cyanamide and triazone urea produces a slow release of nitrogen that 
requires fewer reapplications and is more effective than heretofore fertilizers. In one preferred 
embodiment, the fertilizer or plant treatment is further combined with a soil treatment including 
polycarboxylate acids and polyaliphatic acid salts in combination with potash to further enhance 
the properties of the fertilizer.  
8
Patent AU-2021202091-A1 (AU)
Title: Interior building materials
Inventor: YOKOYAMA ITARU
IPC: E04F13/14
Filed: 2021-04-06
Abstract: INTERIOR BUILDING MATERIALS 
ABSTRACT 
The present invention intends to provide a technique by which, in an interior building material 
which is represented by a gypsum board and to which a magnet does not attach, the surface of 
such an interior building material can be modified so that a magnet can attach to the surface by 
simple means that can be put into practical use, a wall face and the like for which a stopper with 
a magnet, which is a substitute for a thumbtack, and a magnet sheet are usable can thereby be 
formed, and an interior building material which has realized favorable construction efficiency 
such that the interior building material can be easily cut with a cutter knife or the like can be 
made, and this object is realized by providing an interior building material having a plurality of 
sheet-like magnetic materials fixed to at least a portion of a surface or back surface of a plate
like base material to which a magnet does not attach, wherein adjacent magnetic materials are 
disposed in such a way as to have a portion where the adjacent magnetic materials are in contact 
with each other, or adjacent magnetic materials are disposed through a gap having a narrow 
portion.
Patent AU-2021204291-A1 (AU)
Title: A cover for a utility vehicle
Inventor: PORTER ANDREW
IPC: B60J7/08
Filed: 2021-06-24
Abstract: One embodiment of the invention is a cover for the deck of a utility vehicle, wherein the cover is 
formed from a single shell of thermoplastics material and reinforced with an extrusion which, by 
virtue of being formed in aluminium, has a lower co-efficient of expansion relative to the shell. The 
two parts of the cover, shell and extrusion, are secured in such a way that there can be some degree 
of independent movement between them. Effectively, limited thermal expansion of the shell is 
allowed without overly compromising the connection between it and the aluminium extrusion.  
Another invention described herein also relates to a cover for the deck of a utility vehicle wherein 
the cover is connected to the utility vehicle at one end by way of a flexible extrusion which acts as a 
hinge such that as it is raised, it is not only displaced in a vertical orientation but also in a horizontal 
direction as well.
Patent AU-2021204549-A1 (AU)
Title: Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
Inventor: CREW ANDREW P
IPC: C07D417/14
Filed: 2021-06-30
Abstract: The present disclosure relates to bifunctional compounds, which find utility as modulators of estrogen 
receptor (target protein). In particular, the present disclosure is directed to bifunctional compounds, which 
contain on one end at least one of a Von Hippel-Lindau ligand, a cereblon ligand, Inhibitors of Apoptosis 
Proteins ligand, mouse double-minute homolog 2 ligand, or a combination thereof, which binds to the 
respective E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the 
target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target 
protein. The present disclosure exhibits a broad range of pharmacological activities associated with 
degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation 
of the target protein are treated or prevented with compounds and compositions of the present disclosure.
Patent AU-2021209242-A1 (AU)
Title: Systems and methods for implementing density variation (densvar) clustering algorithms
Inventor: SRINIVASAN KARTHIK
IPC: G06N20/00
Filed: 2021-07-28
Abstract: The present disclosure provides a clustering device configured to detect varying density.  
The clustering device may receive a set of parameters (e.g., a density parameter specifying a 
plurality of density values, a size parameter, and a node parameter that includes information 
associated with a plurality of nodes) for identifying clusters. The clustering device may determine 
a distance between different pairs of nodes of the plurality of nodes and identify candidate nodes 
of the plurality of nodes based on the distance determined for the different pairs of nodes and the 
size parameter. Candidate nodes may be assigned to a candidate cluster that may be evaluated 
against the density parameter to determine whether a density of the candidate cluster satisfies at 
least one of the plurality of density values. A cluster may be identified based on whether the 
candidate cluster satisfies at least one of the plurality of density values.
ACNT.PO015US 
700 7/7 
710 Receive, by one or more processors, a set of parameters 
720 Determine, by the one or more processors, a distance between different pairs of 
nodes of the plurality of nodes 
Identify, by the one or more processors, candidate nodes of the plurality of nodes 
730 based on the distance determined for the different pairs of nodes and the size 
parameter 
740 Assign, by the one or more processors, the candidate nodes to a candidate cluster 
750 f Determine, by the one or more processors, whether the candidate cluster satisfies 
at 
least one density value of the plurality of density values 
760 f Identify, by the one or more processors, a density cluster based on whether the 
candidate cluster satisfies the at least one density value 
770 Transmit, by the one or more processors, information associated with the density 
cluster to a remote device 
FIG. 7
Patent AU-2021213894-A1 (AU)
Title: Functional food composition comprising collagen and methods to produce thereof
Inventor: SEIDENSTICKER KURT
IPC: A23L33/00
Filed: 2021-01-27
Abstract: The present invention is directed to functional food compositions comprising collagen. In one embodiment, the invention relates to a collagen and nut protein blend, wherein the composition is a solid or semi-solid that is shelf-stable and has a soft texture. The present invention also includes compositions with other nut protein blends, and compositions that further do not contain gluten. A method of making the compositions of the present invention is also claimed.
Patent AU-2021222056-A1 (AU)
Title: Methods of spatially resolved single cell RNA sequencing
Inventor: CHOW ERIC
IPC: C12Q1/6806
Filed: 2021-02-22
Abstract: The present disclosure generally relates to spatial detection of a nucleic acid, such as a genomic DNA or a RNA transcript, in a cell comprised in a tissue sample. The present disclosure provides methods for detecting and/or analyzing nucleic acids, such as chromatin or RNA transcripts, so as to obtain spatial information about the localization, distribution or expression of genes in a tissue sample. The present disclosure thus provides a process for performing "spatial transcriptomics" or "spatial genomics," which enables the user to determine simultaneously the expression pattern, or the location/distribution pattern of the genes expressed or genes or genomic loci present in a single cell while retaining information related to the spatial location of the cell within the tissue architecture.
Patent AU-2021230595-A1 (AU)
Title: Lift device with deployable operator station
Inventor: MILLER WENTON S
IPC: B60L53/00
Filed: 2021-03-05
Abstract: A lift device includes a lift apparatus and a base assembly. The lift apparatus is configured to raise and lower an implement assembly. The base assembly is configured to support the lift apparatus. The base assembly includes a deployable operator station transitionable between a deployed position and a stowed position. In the deployed position, the deployable operator station is configured to provide a seating and control arrangement for an operator. In the stowed position, the deployable operator station is substantially sealed from an external environment to limit access to the deployable operator station.
Patent AU-2021244617-A1 (AU)
Title: Ultraviolet radiation treatments
Inventor: RAMIREZ-FORT MARIGDALIA KALETH
IPC: A61M25/00
Filed: 2021-03-26
Abstract: Systems, methods, and computer-readable media for enabling ultraviolet radiation treatments are provided.
Patent AU-2021252235-A1 (AU)
Title: Device and method for measuring liquid level in a container by a protected pressure sensor
Inventor: HAYMAN MEIR
IPC: G01F23/14
Filed: 2021-04-05
Abstract: Disclosed herein are a device and method designed for determining the liquid level in a container through measuring the pressure in the liquid by a pressure sensor located at the bottom of the container within a chamber designed to prevent solid particles dispersed in the liquid from reaching the sensor. Measuring the pressure of the liquid in the container can be based on an upper chamber located above a lower chamber, both adjacent chambers are located within a container. The upper chamber comprises tiny slots allowing the liquid in the container to enter the upper chamber and exert a weight on a diaphragm gasket functioning as a common-wall of the two adjacent chambers. The diaphragm gasket exerts pressure resulting from the liquid weight, on the lower chamber containing the pressure sensor designed to measure the pressure exerted on the lower chamber.
Patent AU-2021255553-A1 (AU)
Title: Folding apparatus and electronic device
Inventor: NIU LINHUI
IPC: H04M1/02
Filed: 2021-04-15
Abstract: Disclosed by the present application are a folding apparatus and electronic device. A rotating mechanism of the folding apparatus comprises a main shaft, a first fixed frame, a first transmission arm, a first rotating arm, a first support plate, a second fixed frame, a second transmission arm, a second rotating arm and a second support plate. One end of the first transmission arm is slidably connected to the first fixed frame, the other end is rotationally connected to the main shaft, two ends of the first rotating arm are rotationally connected to the first fixed frame and the main shaft respectively, and the first support plate is set between the first fixed frame and the main shaft and is fixedly connected to the first rotating arm. One end of the second transmission arm is slidably connected to the second fixed frame, the other end of the second transmission arm is rotationally connected to the main shaft, two ends of the second rotating arm are rotationally connected to the second fixed frame and the main shaft respectively, and the second support plate is set between the second fixed frame and the main shaft and is fixedly connected to the second rotating arm. A bending mechanism of the folding apparatus can strongly support a flexible display screen, so that the flexible display screen has high reliability and a long service life.
Patent AU-2021260581-A1 (AU)
Title: Oligonucleotides for MSH3 modulation
Inventor: KHVOROVA ANASTASIA
IPC: C12N15/09
Filed: 2021-04-20
Abstract: This disclosure relates to novel MSH3 targeting sequences. Novel
Patent AU-2021261868-A1 (AU)
Title: Monoclonal antibodies against HER2
Inventor: GOEIJ BART DE
IPC: A61K39/00
Filed: 2021-11-02
Abstract: MONOCLONAL ANTIBODIES AGAINST HER2 
ABSTRACT 
Isolated monoclonal antibodies which bind to human epidermal growth factor 
receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed.  
Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic 
methods for using the antibodies are also disclosed.
Patent AU-2021262720-A1 (AU)
Title: Protein-fortified beverages for enhanced athletic performance
Inventor: CASTRO JENNIFER
IPC: A23C9/15
Filed: 2021-04-23
Abstract: Protein-containing beverages are described. The beverages may include water and 2 wt.% to 8 wt.% protein (based on the total weight of the beverage). The protein in the beverage may include whey protein. The whey protein has at least 12 wt.% of the branched-chain amino acid leucine (based on the total weight of the whey protein). The beverage may also include casein protein. Methods of making protein-containing beverage products are also described. The methods may include providing a protein-containing aqueous mixture, homogenizing and pasteurizing the protein-containing aqueous mixture, and bottling the homogenized and pasteurized protein-containing aqueous mixture to form the protein-containing beverage product. The protein-containing aqueous mixture may include casein protein, and whey protein having at least 12 wt.% leucine (based on the total weight of the whey protein).
Patent AU-2021269324-A1 (AU)
Title: Compositions and methods utilizing lysophosphatidylcholine scaffolds
Inventor: SILVER DAVID LAWRENCE
IPC: G01N33/50
Filed: 2021-11-16
Abstract: COMPOSITIONS AND METHODS UTILIZING LYSOPHOSPHATIDYLCHOLINE 
SCAFFOLDS 
Abstract 
The invention relates to compositions and methods for utilizing lysophosphatidylcholine 
scaffolds. The compositions and methods can be used for LPC-mediated delivery of fatty acids 
and other molecules; to screen and identify fatty acid formulations for parenteral nutrition; and 
for live animal organ imaging, among other uses. The invention also provides compositions and 
methods for utilizing mutations and polymorphisms in human Mfsd2a as markers for 
neurological deficits.
Patent AU-2021275233-A1 (AU)
Title: Competitive and noncompetitive inhibitors of the muscarinic acetylcholine receptor M5
Inventor: LINDSLEY CRAIG W
IPC: A61K31/437
Filed: 2021-05-21
Abstract: Arylsulfonamides of 4-heteroaryl-piperidines, and their derivatives, are competitive and non-competitive inhibitors of the muscarinic acetylcholine receptor M5 (mAChR M
Patent AU-2021286422-A1 (AU)
Title: End-to-end speaker recognition using deep neural network
Inventor: KHOURY ELIE
IPC: G10L17/04
Filed: 2021-12-17
Abstract: The present invention is directed to a deep neural network (DNN) having a triplet network 
architecture, which is suitable to perform speaker recognition. In particular, the DNN 
includes three feed-forward neural networks, which are trained according to a batch process 
utilizing a cohort set of negative training samples. After each batch of training samples is 
processed, the DNN may be trained according to a loss function, e.g., utilizing a cosine 
measure of similarity between respective samples, along with positive and negative margins, 
to provide a robust representation of voiceprints.  
18344358_1 (GHMatters) P110869.AU.1
Patent AU-2021292195-A1 (AU)
Title: Crystalline forms of a CD73 inhibitor and uses thereof
Inventor: PENNELL ANDREW M K
IPC: C07H19/14
Filed: 2021-06-16
Abstract: Crystalline forms of the compound of Formula (I), which modulates the conversion of AMP to adenosine by 5'-nucleotidase, and compositions containing the compound and methods for preparing the crystalline forms, are described herein. The use of such crystalline form of Formula (I) and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer and immune-related disorders, that are mediated by 5'-nucleotidase is also provided.
Patent AU-2021302956-A1 (AU)
Title: Methods for producing urea calcium sulfate from moist phosphogypsum
Inventor: KELLS ANDREW GEORGE
IPC: C05C9/00
Filed: 2021-06-29
Abstract: Method for producing a urea calcium sulfate (UCS) adduct is disclosed. The method for producing the UCS adduct, includes contacting urea with a moist phosphogypsum containing 10 wt. % to 30 wt. % of moisture, under conditions sufficient to form a slurry comprising formed UCS adduct.
Patent AU-2021307605-A1 (AU)
Title: Electrical connections for supplying power to insulating glass unit interiors, and/or associated methods
Inventor: MATUSZEWSKI JOHN
IPC: E06B3/663
Filed: 2021-07-15
Abstract: Certain example embodiments relate to an insulating glass (IG) unit. A spacer is interposed between first and second substrates. The spacer helps maintain the substrates in substantially parallel spaced apart relation to one another, and helps define a cavity therebetween. First and second exterior surfaces of the spacer face interior surfaces of the first and second substrates, respectively. Third and fourth exterior surface of the spacer face towards and away from the cavity, respectively. A membrane is provided over at least a part of the fourth exterior surface of the spacer. A pin protrudes through holes in the third and fourth exterior surfaces of the spacer, and through the membrane. The pin is formed from an electrically conducting material. A structural seal for the IG unit is provided external to the spacer and at least partially surrounds a portion of the pin that protrudes through the membrane.
Patent AU-2021331485-A1 (AU)
Title: Methods for the prevention of cholesterol crystal embolization with cyclodextrins
Inventor: KERWIN DIANA
IPC: A61K9/10
Filed: 2021-08-27
Abstract: Disclosed herein are methods for preventing or reducing the risk of developing, and/or preventing or reducing the risk of an increase in an amount of and/or a size of, and/or changing the shape of, circulating (e.g., blood, serum, plasma) cholesterol crystals (and/or clots comprising cholesterol crystals) in an individual. Further disclosed herein are methods of preventing or reducing the risk of cholesterol crystal embolization (CCE) and/or a symptom thereof in an individual. The methods generally involve administering a therapeutically effective amount of 2-hydroxypropyl-beta-cyclodextrin to the individual. Further provided herein are pharmaceutical compositions comprising a therapeutically effective amount of 2-hydroxypropyl-beta-cyclodextrin and a pharmaceutically acceptable excipient.